Cognizant · 1 day ago
Software Development Engineer in Test (SDET) with Gen AI/ Selenium/ Playwright experience
Cognizant is seeking a Software Development Engineer in Test (SDET) with expertise in Gen AI, Selenium, and Playwright. The role involves leading automation initiatives, mentoring QA team members, and collaborating with various stakeholders to ensure high-quality software delivery.
ConsultingIndustrial AutomationInformation TechnologySoftwareSoftware Engineering
Responsibilities
Lead and mentor QA team members to strengthen testing practices
Define and implement test strategies and test plans
Manage release activities and ensure timely, quality delivery
Debug and execute automated scripts using Playwright and Selenium
Estimate testing efforts and provide accurate timelines
Collaborate with cross-functional teams to align on quality goals
Qualification
Required
12+ years of QA experience with agile practices
Expertise in writing, enhancing, and executing automated scripts using Playwright and Selenium
Hands-on experience with Java and TypeScript
Strong knowledge of QA processes and frameworks (Keyword Driven, Hybrid)
Experience with REST Assured, JUnit/TestNG, and build tools like Maven
Proficiency in version control tools such as GitHub
Excellent communication skills
Preferred
Experience with LLM models, Amazon Kendra, Amazon Bedrock, and embedding strategies
Ability to customize automation frameworks for complex scenarios
Strong problem-solving skills and ability to debug intricate automation issues
Proven track record of mentoring and leading QA teams
Familiarity with emerging technologies and AI-driven testing approaches
Benefits
Medical/Dental/Vision/Life Insurance
Paid holidays plus Paid Time Off
401(k) plan and contributions
Long-term/Short-term Disability
Paid Parental Leave
Employee Stock Purchase Plan
Company
Cognizant
Cognizant is a professional services company that helps clients alter their business, operating, and technology models for the digital era.
Funding
Current Stage
Public CompanyTotal Funding
$0.24MKey Investors
Summit Financial Wealth Advisors
2025-03-08Post Ipo Equity
2016-11-18Post Ipo Equity· $0.24M
1998-06-19IPO
Recent News
2026-01-06
2026-01-05
Company data provided by crunchbase